Following the announcement of new blood component, scientific discoveries continue with surprising revelations in T cell activation. This time the researchers discovered oneImmune cell from the T cell family, which can effectively fight many types of cancer. The Welsh team stumbled upon the big discovery by chance and explained that the cells in question attack cancer cells and ignore healthy ones.
So, this new immune cell belongs to the T-lymphocyte (T-cell) family and tends to fight against various types of cancer, which could help create a therapeutic approach such as immunotherapy. The so-called “T cells” scan the surface of cells to detect abnormalities and eliminate cancer cells that secrete abnormal proteins while ignoring healthy cells.
One of the possiblenew cancer therapiesconsists of influencing the immune system so that it can attack the disease. In other words, the patient's immune cells can genetically change to "arm" them against the tumor.
To do this, the researchers took T lymphocytes (used to fight infections) from the blood, then multiplied and modified them to obtain a specific receptor, and finally reintroduced them into the body to detect and eliminate cancer cells. They called this therapy “CAR-T cells”. However, it is only suitable for treating certain types of cancer. Not to mention that scientists need to develop an individual approach. They then have to adapt this to each patient, which makes the process itself too long and complicated. And this is where the new immune cell comes into play.
New immune cells are set to revolutionize cancer treatment
The new immune cell has a new T cell receptor (TCR). The researchers therefore confirmed that it can eliminate the cells of lung, colon, skin, breast, ovarian, cervical and prostate cancer. Scientists tested their discovery by injecting mice that were infected with human cancer and had human immune systems. According to experts, the results are very encouraging and promise successful treatment against cancer.
